# Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II

> **NCT00247169** · PHASE2 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 40 (actual)

## Conditions studied

- Cervical Intraepithelial Neoplasia

## Interventions

- **DRUG:** progesterone

## Key facts

- **NCT ID:** NCT00247169
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2009-04
- **Final completion:** 2010-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00247169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00247169, "Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00247169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*